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Abstract
Cannabinoid receptors mediate short-term retrograde inhibition of neurotransmitter release, as well as long-term depression of synaptic transmission at excitatory synapses. The responses of individual nerve terminals in VGLUT1-pHluorin transfected cerebellar granule cells to cannabinoids have shown that prolonged activation of cannabinoid type 1 receptors (CB1Rs) silences a subpopulation of previously active synaptic boutons. Adopting a combined pharmacological and genetic approach to study the molecular mechanisms of CB1R-induced silencing, we found that adenylyl cyclase inhibition decreases cAMP levels while it increases the number of silent synaptic boutons and occludes the induction of further silencing by the cannabinoid agonist HU-210. Guanine nucleotide exchange proteins directly activated by cAMP (Epac proteins) mediate some of the presynaptic effects of cAMP in the potentiation of synaptic transmission. ESI05, a selective Epac2 inhibitor, and U-73122, the specific inhibitor of phospholipase C (PLC), both augment the number of silent synaptic boutons. Moreover, they abolish the capacity of the Cannabinoid type 1 receptors (CB1Rs) mediate retrograde short-term inhibition, as well as long-term depression of excitatory synaptic transmission (Castillo et al. 2012) . The short-term effects of CB1Rs are attributed to the inhibition of the Ca 2+ influx at nerve terminals (Brown et al. 2004) , while long-term depression of synaptic transmission can also be induced by persistent activation of cannabinoid receptors (Gerdeman et al. 2002; Kreitzer and Malenka 2005; SolerLlavina and Sabatini 2006; Chevaleyre et al. 2007 ). We recently found that prolonged stimulation of cannabinoid receptors in cerebellar granule cells silences a subpopulation of synaptic boutons that were previously active. Moreover, such silencing is prevented by increasing cAMP, and it is associated with a reduction in the active zone Rab3-interacting molecule (RIM)1a protein and with fewer synaptic vesicles (SVs) accumulating close to the plasma membrane (Ram ırez-Franco et al. 2014) . This explains why presynaptic silencing is not reversed by increasing Ca 2+ influx (Moulder et al. 2004; Ram ırez-Franco et al. 2014) . Thus, cannabinoid-induced silencing may represent the response of those nerve terminals with a weak release apparatus.
Presynaptic silencing may offer neurons protection during excitotoxic insults (Hogins et al. 2011) . Moreover, cannabinoid-dependent silencing could be involved in certain forms of synaptic plasticity induced by cannabinoid receptor type 1 (CB1R) stimulation (Gerdeman et al. 2002; Kreitzer and Malenka 2005; Soler-Llavina and Sabatini 2006; Chevaleyre et al. 2007) , including endocannabinoid-induced long-term potentiation at synapses between cerebellar granule cells and Purkinje cells (Safo and Regehr 2005; Carey et al. 2011) . Presynaptic silencing is associated with low RIM1a content (Rab3 interacting molecule 1a), and it can be overcome by RIM1a over-expression (Jiang et al. 2010) , which is consistent with the decrease in docked SVs observed after RIM protein deletion (Calakos et al. 2004; Kaeser et al. 2011) . RIM proteins are key elements in neurotransmitter release (Schoch et al. 2002) , as they recruit Ca 2+ channels to the release sites , and they promote the heterodimer formation with Munc13 proteins , an event that is essential to prime SVs for release (Ma et al. 2011) . CB1Rs decrease cAMP levels, yet how cAMP targets the release machinery proteins to silence nerve terminals is not known. Interestingly, guanine nucleotide exchange proteins directly activated by cAMP (Epac proteins) have emerged as an alternative cAMP target to cAMP-dependent protein kinase (PKA) (Kawasaki et al. 1998) . Epac proteins mediate cAMP-dependent enhancement of synaptic transmission (Kaneko and Takahashi 2004; Huang and Hsu 2006; Gekel and Neher 2008; Fernandes et al. 2015) , glutamate release (Ferrero et al. 2013 ) and synaptic plasticity (Yang et al. 2012) , and of the two known Epac isoforms, Epac2 is expressed abundantly in the brain, including the cerebellum (Kawasaki et al. 1998) . However, it is not clear whether Epac2 mediates the cAMP responses involved in cannabinoid-induced silencing. The signaling pathway downstream of Epac proteins targeting the release machinery involved in presynaptic silencing also remains to be described.
We combined pharmacological and genetic approaches to study the molecular mechanisms of CB1R-induced silencing in cerebellar granule cells. We found that the adenylyl cyclase inhibitor SQ22536 augmented the number of silent synaptic boutons. ESI05, a selective inhibitor of Epac2, and the specific inhibitor of phospholipase C (PLC), U-73122, also increased the number of silent synaptic boutons, and they abolished the capacity of the Epac activator 8-(4-chlorophenylthio)-2 0 -O-methyladenosine 3 0 ,5 0 -cyclic monophosphate monosodium hydrate (8pCpt) to prevent HU-210-induced silencing, consistent with PLC signaling lying downstream of Epac2. Furthermore, in RIM1a KO cells more basally silent synaptic boutons were evident. In these cells, HU-210 induced further silencing and while 8pCpt prevented HU-210 from silencing boutons, it failed to awaken the basally silent synaptic boutons. The behavior of the boutons in these RIM1a KO cells was rescued by reinstating RIM1a expression. Thus, a cAMP/Epac/PLC signaling pathway that targets the release machinery appears to mediate cannabinoid-induced presynaptic silencing in cerebellar granule cells.
Materials and methods
Primary culture of cerebellar neurons Primary cultures of cerebellar granule cells were established by dissociating the cerebellum isolated from 7-day-old (P7) male or female Wistar albino rat pups (Animal Facility of the Universidad Aut onoma de Madrid), as described previously (Bartolom e-Mart ın et al. 2012). Cultures were also prepared from 5 to 6-day-old pups of C57BL/6 wild-type and RIM1a KO mice (Schoch et al. 2002) , provided by the Animal Facility of the Universidad Complutense de Madrid, that were killed by cervical dislocation. The cells were seeded onto poly-L-lysine coated coverslips (1-3 9 10 6 cells/ coverslip), or in 96-or 6-well tissue culture plates (10 5 or 3.5 9 10 6 cells/well, respectively), and they were maintained in a humidified incubator at 37°C in an atmosphere of 5% CO 2 . The experiments were carried out after 7-8 days in vitro (DIV). This is a highly pure granule cell preparation and although it may contain some types of interneurons, they always represent less than 10% of the cultured neurons (Gallo et al. 1982) . All procedures with animals were conducted under the ethical guidelines for animal experimentation and the regulations established by the European Council (Directive 2010/63/EU). The experimental protocol was approved by the Commission of Animal Experimentation at the Complutense University. All efforts were made to minimize the number of animals used and their suffering. Wang et al. 2000) . Experiments were performed at 7 DIV and initially, the cells were maintained in calcium-free HEPES Buffer Medium (HBM) buffer with 5 mM potassium and with or without the drugs indicated in the figure legends. In single pulse experiments, after a 30 s baseline, the cells were stimulated for 10 s with 50 mM KCl, and after a 1 min recovery, a second 30 s pulse of NH 4 Cl was delivered to estimate the maximal signal. Images were captured at an acquisition rate of 4 Hz and averaged to a single frame per second to enhance the signal-to-noise ratio, resulting in an actual readout of 0.7 Hz.
Epac2 knockdown experiments

Analysis of vGlut1-pHluorin experiments
Images were obtained on a Nikon Eclipse TE2000-S microscope equipped with a Nikon (Amsterdam, Netherland) CFI Plan Apo VC 609 Oil 1.4 (NA) and a CCD camera (iXonEM+DU885; Andor Technology, Belfast, UK). Andor iQ 1.9.1 software was used for image acquisition. A 479-nm monochromator was used for excitation and the emitted light was collected, using a fluorescein isothiocyanate filter. Images were analyzed using ImageJ software (http://rsbweb.nih.gov/ij) and in the vGlut1-pHluorin experiments, background subtraction was carried out by averaging several cellfree regions and subtracting this value from each individual region of interest (ROI). ROIs were defined manually as NH 4 Cl-responsive puncta with a diameter > 1 lm and somatic regions were excluded from the analysis. After background subtraction, the averaged value of the ten first frames of each ROI was subtracted to calculate the zero value under basal conditions. The maximal signal during NH 4 Cl perfusion was used to normalize each trace, resulting in values ranging from 0 to 1. Boutons were classified as silent when the signal elicited by 50 mM KCl perfusion was less than 4% of the NH 4 Cl signal. This threshold was selected as it corresponds to the average noise of the individual traces.
Electron microscopy
To visualize the arrangement of the SVs within the presynaptic terminals, cultured cerebellar granule cells from wild-type rats were maintained for 10 min in low-potassium HBM buffer in the presence or absence of HU-210 (5 lM) or 8pCpt/HU-210 (8pCpt: 50 lM, 15 min). The cells were then washed and fixed for 2 h at 4°C with 4% paraformaldehyde/2.5% glutaraldehyde in Millonig's sodium phosphate buffer (0.1 M, pH 7.3), they were washed twice and incubated overnight at 4°C in Millonig's buffer before postfixing in 1% OsO 4 /1.5% K 3 Fe(CN) 6 for 1 h at 23°C and dehydrating in ethanol. The cells were kept on the coverslips until they were embedded in SPURR (SPURR embedding kit; TAAB, Aldermaston, England) and after polymerization, the coverslips were removed with liquid N 2 . Ultrathin sections (70 nm) were routinely stained with uranyl acetate and lead citrate, and images were obtained on a JEM 1010 transmission electron microscope (JEOL Ltd, Tokyo, Japan). Measurements were made with ImageJ software. The experiments were not blind to treatment/genotype, but they were strictly analyzed following the same criteria in all the conditions. The ultrastructure analysis is based in the measurement of distance from the SV to the plasma membrane using the outer membrane of the SVs and the inner layer of the AZ plasma membrane as reference points and this criteria has been strictly maintained in the different samples. The relative number of SVs per active zone (AZ) was calculated in 10 nm bins from the membrane at the AZ. The mean number of SVs in the first 10 nm from the AZ and the total number of SVs per synaptic terminal were also determined. Only synapses with a notable postsynaptic membrane were analyzed. 
Statistical analysis
The data were analyzed using Statgraphic (Statpoint Technologies Inc, The Plains, VA, USA), OriginPro 8.0 (OriginLab Corporation, Northamton, MA, USA) or SigmaPlot 10 software (Systat Software, Inc., San Jose, CA, USA). The specific test applied in each case is indicated in the text. The data are represented as the mean AE SEM: *p < 0.05, **p < 0.01, ***p < 0.001. Differences were considered statistically significant when p < 0.05 with a confidence limit of 95%.
Results
The prolonged activation of CB1Rs at individual synaptic boutons silences a subpopulation of previously active synaptic boutons (Ram ırez-Franco et al. 2014). We examined the molecular mechanisms underlying cannabinoidinduced silencing in cerebellar granule cells transfected with vGlut1-pHluorin, which allowed us to track the exoendocytotic cycle. In these cells, depolarization increases fluorescence as a result of the exposure of vGlut1-pHluorin to the neutral extracellular milieu. This increase in fluorescence is followed by a decrease produced by the compensatory endocytosis and fluorescent quenching at the acidic intravesicular pH. Alkalinization of the entire synaptic vesicle population with NH 4 Cl generates maximal n.s.
p > 0.05; **p < 0.01; ***p < 0.001, compared to control unless otherwise indicated. (f) The cAMP levels in cerebellar granule cells in the same conditions as in C and after exposure to forskolin (50 lM, 15 min). **p < 0.01; ***p < 0.001 vs basal cAMP levels.
fluorescence allowing the recycled SV pool to be estimated. We analyzed the response to depolarization (50 mM KCl, 10 s) of all the individual nerve terminals in a field of cerebellar granule cells at 7 DIV. In control conditions (Fig. 1a) , most synaptic boutons respond to KCl depolarization with a transient increase in fluorescence (examples 1 and 2 in Fig. 1b, control) giving rise to an averaged exoendocytotic response of 29.6 AE 0.8% of the total SVs, number of synaptic boutons n = 267, number of coverslips N = 6 (Fig. 1c and d, control) . Thus, this stimulation protocol recycles a SV pool fraction similar to that found in hippocampal neurons (Kim and Ryan 2010) . However, in cells treated with the cannabinoid agonist HU-210 (5 lM, 10 min: Fig. 1a cAMP CB1Rs signal through several pathways and they inhibit adenylyl cyclase to reduce transmitter release (Vogel et al. 1993; Godino et al. 2005) . As the CB1R-mediated decrease in cAMP has been associated with a long-term depression of synaptic transmission (Chevaleyre et al. 2007 ), we first tested whether decreased cAMP levels are responsible for cannabinoid-induced silencing. Accordingly, we analyzed whether the adenylyl cyclase inhibitor SQ22536 increased the number of silent synaptic boutons and occluded the ability of HU-210 to induce further silencing. SQ22536 (100 lM, 25 min: Fig. 1a ) reduced the average fluorescence response of the population of nerve terminals ( Fig. 1c and d . This is consistent with the notion that cAMP augments the number of functional presynaptic boutons (Ma et al. 1999) .
As cAMP levels determine the silent state of synaptic boutons, we tested whether activation of G protein-coupled receptors coupled to cAMP generation prevent HU-210-induced silencing. Gs-coupled b-adrenergic receptors (bARs) are expressed in cerebellar granule cells (Nicholas et al. 1993 ), so we examined whether b-AR activation prevented HU-210-induced silencing. The b-AR agonist isoproterenol slightly augmented the peak fluorescence response of the whole population of nerve terminals (Fig. 2b  and c) , although the number of silent nerve terminals was not significantly altered (1.0 AE 0.5 and 0.5 AE 0.3% in isoproterenol treated and control cells, respectively, p = 1, Kruskal-Wallis ANOVA with Dunn 0 s multiple comparisons test: Fig. 2d ). However, isoproterenol did prevent HU-201 induced silencing (0.8 AE 0.5%, p = 0.9999, Kruskal-Wallis ANOVA with Dunn 0 s multiple comparisons test: Fig. 2d ). This data provide further evidence that a decrease in cAMP could be responsible for cannabinoid-induced silencing.
Epac
As increasing the amount of cAMP prevents HU-210-induced silencing through a PKA-independent mechanism (Ram ırez-Franco et al. 2014), we tested the influence of other cAMP targets. Epac proteins are directly activated by cAMP and they have emerged as alternative cAMP targets to PKA (Bos 2006) , with Epac2 representing the main isoform in the brain (including the cerebellum: Kawasaki et al. 1998) . To directly assess the role of Epac2 activity in determining the state of synaptic boutons, we silenced Epac2, using siRNAs. An Epac2 siRNA added to cerebellar granule cells for 72 h (at 4 DIV) reduced the amount of Epac2 mRNA to 26.7 AE 1.0% that of the controls, p = 0.0001, ANOVA with Bonferroni 0 s test, while a non-targeting siRNA used as a control only marginally reduced the Epac2 mRNA (89.1 AE 1.0% of the control: Fig. 3a) . Thus, we assessed whether Epac2 knockdown specifically induces silencing and whether it alters the ability of the Epac activator 8pCpt to prevent HU-210-induced silencing (Fig. 3b) . While 8pCpt fully prevented HU-210-induced silencing in untreated cells (1.6 AE 0.5 and 2.8 AE 0.9% of silent boutons in control and 8pCpt + HU-210, respectively, p = 0.9509, Kruskal-Wallis ANOVA with Dunn 0 s multiple comparisons test: Fig. 3c , f and i) and in those that were treated with a non-targeting siRNA (1.0 AE 0.3 and 1.5 AE 0.4% of silent boutons in control and 8pCpt + HU-210, respectively, p = 0.9999, Kruskal-Wallis ANOVA with Dunn 0 s multiple comparisons test: Fig. 3e , h and k), this effect was suppressed in cells treated with Epac2 siRNA (2.4 AE 1.3 and 15.3 AE 2.7% of silent boutons in control and 8pCpt + HU-210, respectively, p = 0.0008, ANOVA with Bonferroni 0 s test: Fig. 3d, g and j) . However, Epac2 siRNA did not increase the number of silent synaptic boutons in control conditions (1.6 AE 0.5 and 2.4 AE 1.3% in untransfected and siRNA transfected cells, respectively, p = 0.5837, Welch's t-test Fig. 3i and j) . We also tested whether an increase in Epac1 expression during treatment with Epac2 siRNA accounts for the absence of silencing. However, we found that Epac mRNA levels were similar in control (0.98 AE 0.02) and Epac2 siRNA-treated cells (0.94 AE 0.03), p = 0.40138 ( Figure S1 ). As Epac2 is abundantly expressed in the brain, whereas Epac1 expression in the brain is very low (Kawasaki et al. 1998) it is likely that the lack of silencing after siRNA Epac2 knockdown is because of the remaining Epac2 activity.
To further assess the role of Epac2 in cannabinoid-induced silencing we used the recently developed selective Epac2 inhibitor, ESI05, which binds to the interface formed between the two unique cAMP-binding domains of Epac2 (Tsalkova et al. 2012) . We found that ESI05 (10 lM, 20 min: Fig. 4a ) decreased the average fluorescent response of the synaptic boutons relative to the controls (Fig. 4b and  c) , and it apparently increased, although not significantly, the number of silent synaptic boutons from 0.6% (AE 0.2) in the controls to 6.3% (AE 1.1%, p = 0.1163, Kruskal-Wallis ANOVA test with Dunn 0 s multiple comparison test: Fig. 4d ). However, ESI05 (10 lM, the same concentration) fully abolished the ability of 8pCpt to prevent HU-210-induced silencing (2.6 AE 0.9 and 15.9 AE 2.7% in 8pCpt/HU210 and ESI-05/8pCpt/HU210, respectively, p = 0.0064, KruskalWallis ANOVA test with Dunn 0 s multiple comparison test: Fig. 4d) . Interestingly, higher concentrations of ESI05 (25 lM, 20 min) significantly increased the number of silent synaptic boutons (0.5 AE 0.9 and 14.1 AE 1.7% in control and ESI05, respectively, p = 0.0008, Kruskal-Wallis ANOVA test with Dunn 0 s multiple comparison test: Fig 4d) . Thus, strong inhibition of the cAMP target protein Epac2 seems to be required to effectively silence synaptic boutons.
PLC
Since Epac2 inhibition silences synaptic boutons while Epac2 activation awakens synaptic boutons previously silenced by cannabinoids, Epac2 proteins are apparently determinants of the state of cerebellar granule cell nerve terminals. Epac proteins mediate cAMP-dependent enhancement of synaptic transmission (Gekel and Neher 2008; Fernandes et al. 2015) , as well as the b-AR-dependent potentiation of glutamate release (Ferrero et al. 2013 ).
However, how Epac2 proteins modulate neurotransmitter release and exocytosis is not well established. Epac proteins have been characterized as guanine nucleotide exchange factors for monomeric GTPases like Rap1 (Kawasaki et al. 1998) and Rab3a (Branham et al. 2009 ). PLC-e is a direct target of Rap1 (Schmidt et al. 2001) and PLC-e is required for Epac2-mediated potentiation of insulin secretion (Dzhura et al. 2011) . Furthermore, Epac activation increases phosphatidylinositol (4,5)-bisphosphate hydrolysis and the translocation of the AZ protein Munc13-1 to central synapses (Ferrero et al. 2013) . To determine whether PLC signals downstream of Epac2, we used the PLC inhibitor U-73122. Specifically, we addressed whether inhibiting PLC induces n.s.
p > 0.05; **p < 0.01; ***p < 0.001, compared to control unless otherwise indicated.
silencing and whether U-73122 alters the capacity of the Epac activator 8pCpt to prevent HU-210-induced silencing. Exposure to U-73122 (2 lM, 20 min: Fig. 5a ) appeared to decrease the average fluorescence response of synaptic boutons relative to the controls (Fig. 5b and c) , as well as inducing an apparent increase in the number of silent synaptic boutons, albeit not significant (0.4 AE 0.2 and 3.9 AE 1.6% in control and U-73122-treated cells, respectively, p = 0.9999, Kruskal-Wallis ANOVA test with Dunn 0 s multiple comparisons test: Fig. 5d ). However, U-73122 (2 lM) fully abolished the ability of 8pCpt to prevent HU-210-induced silencing (1.7 AE 0.7 and 17.5 AE 4.6% of silent boutons in 8pCpt/HU-210 and U73122/8pCpt/HU-210, respectively, p = 0.0018, Kruskal-Wallis ANOVA test with Dunn 0 s multiple comparisons test: Fig. 5d ). Interestingly, higher concentrations of U73122 (4 lM, 20 min) significantly increased the number of silent synaptic boutons (0.3 AE 0.3 and 23.8 AE 5.4% in control and U73122, respectively, p = 0.0001, Kruskal-Wallis ANOVA test with Dunn 0 s multiple comparisons test: Fig. 5d ). 
RIM1Α
Epac2 interacts with the active zone protein RIM1 (Ozaki et al. 2000) , a key element in the modulation of neurotransmitter release. RIM proteins tether Ca 2+ channels to the presynaptic AZ , and they activate vesicle priming by reversing the auto-inhibitory homodimerization of Munc13 . In addition, RIM proteins regulate the size of the readily releasable pool of SVs (Dulubova et al. 2005; Han et al. 2011; Kaeser et al. 2011) . Thus, RIM1a determines the extension of the AZ and the release probability, thereby defining synaptic efficacy (Holderith et al. 2012) . We tested the role of RIM1a in synaptic bouton silencing as this protein determines the release properties of cerebellar granule cell terminals (Kintscher et al. 2013) . We used a two-pulse protocol, with HU-210 being added in the interpulse interval, to distinguish synaptic boutons silenced by the lack of RIM1a protein (basally silent) and HU-210-induced silent synaptic boutons in cerebellar granule cells from wild-type and RIM1a KO mice, and those from RIM1a KO mice transfected with a Cerebellar granule cells were exposed to HBM, stimulated with KCl (50 mM, 10 s) and then perfused with NH 4 Cl (50 mM, pulse 1) to determine the silent synaptic boutons. The cells were then either maintained in HBM alone (control black traces) or treated with HU-210 (5 lM, 10 min, red traces) during the inter-pulse interval, and the silent synaptic boutons were again quantified with KCl (50 mM, 10 s) followed by NH 4 Cl perfusion (50 mM, pulse 2). The cells were also treated with 8pCpt (50 lM, 15 min) before pulse 1 and then with 8pCpt/HU-210 (5 lM, 10 min, blue traces) in the inter-pulse interval. n.s.
p > 0.05; **p < 0.01 and ***p < 0.001 compared to wild-type pulse 1 control unless otherwise indicated.
RIM1a plasmid (RIM1a KO rescue: Fig. 6a ). While wildtype cells have a low level of basally silent synaptic boutons in control conditions (1.1 AE 0.5%, Fig. 6e) , a much higher level of synaptic silencing was found in RIM1a KO cells (12.9 AE 3.5%, p = 0.0001, Kruskal-Wallis ANOVA test with Dunn 0 s multiple comparisons test: Fig. 6f ). However, the low level of basally silent synaptic boutons was restored in RIM1a KO cells transfected with RIM1a plasmid (0.7 AE 0.5%, p = 0.9999, Kruskal-Wallis ANOVA test with Dunn 0 s multiple comparisons test: Fig. 6g ). Exposure to HU-210 increased the number of silent synaptic boutons from 1.3 AE 0.6 to 26.4 AE 6.3%, p = 0.0018, Welch 0 s t-test, in wild-type cells and from 14.1 AE 4.7 to 42.5 AE 8.0%, p = 0.0055, Student 0 s t-test, in RIM1a KO cells, despite the larger number of basally silent synaptic boutons in these cells. HU-201 also induced synaptic silencing in RIM1a KO rescued cells, from1.4 AE 0.8 to 36.8 AE 9.5%, p = 0.0076, Welch 0 s t-test, (Fig. 6g) (Fig. 6e-g ), although it did not affect the high level of basally silent synaptic boutons in RIM1a KO cells (Fig. 6f) , indicating that Epac2 proteins act upstream of RIM1a.
Further evidence that an Epac-dependent signaling pathway determines the active/silent state of synaptic boutons was obtained by studying the distribution of SVs at the active zone by electron microscopy of cultured cerebellar granule cells. Exposure to HU-210 decreases the number of SVs close to the plasma membrane AZ (0.5 AE 0.1in HU-210 compared to control cells 3.6 AE 0.2 p = 4.79E-19, ANOVA with Bonferroni 0 s test: Fig. 7 (a) and (b), and inset in b), while Epac activation with 8pCpt prior to HU-210 treatment impeded this change in SV distribution (3.7 AE 0.3, p = 1, ANOVA with Bonferroni 0 s test p > 0.05: Fig. 7 (a) and (b), and inset in b). None of these treatments modified the total number of SVs/per release site (48.0 AE 3.2% in control and 47.4 AE 2.7%, p = 1, in HU-210 and 54.1 AE 2.9, p = 0.44, in 8pCpt/HU-210-treated cells, ANOVA with Bonferroni 0 s test: Fig. 7c) . Thus, HU-210-induced silencing is consistent with the retraction of SVs from the plasma membrane, preventing their fusion, while Epac activation keeps SVs close to the plasma membrane.
Discussion
We have investigated the signaling pathways involved in cannabinoid HU-210-induced silencing of synaptic boutons, a process that is mimicked by lowering cAMP with the adenylyl cyclase inhibitor SQ22536 or by specific inhibition of the cAMP target protein Epac2. PLC inhibition not only induces presynaptic silencing but it also abolishes the ability of the Epac activator 8pCpt to prevent HU-210-induced silencing, indicating that PLC signals downstream of the Epac proteins. As opposed to wild-type cells, cells lacking RIM1a have many basally silent synaptic boutons, although the low level of basally silent nerve terminals is reinstated when RIM1a is restored. Moreover, the cannabinoid agonist HU-210 still induced further silencing in these RIM1a KO cells. Thus, the silencing of presynaptic boutons by persistent CB1R activation (10 min) is the consequence of a strong down-regulation of a cAMP/EPAC/PLC signaling pathway that targets the release machinery and that diminishes the number of SVs close to the AZ in the plasma membrane (Fig. 8) .
In a previous study, we observed that CB1R-induced silent synapses represent a fraction of the CB1-expressing nerve terminal in the culture of cerebellar granule cells indicating that the expression of CB1R is not the only determinant of presynaptic silencing. In addition, increasing the Ca cAMP is central to maintain presynaptic activity, particularly since increasing cAMP levels potentiates neurotransmitter release at many synapses (Weisskopf et al. 1994; Herrero and S anchez-Prieto 1996; Huang and Hsu 2006) , as well as the number of functional release sites (Bolshakov et al. 1997; Ma et al. 1999) . Presynaptic silencing is associated with a reduction in cAMP at nerve terminals. Thus, increasing cAMP levels prevents the presynaptic silencing induced by chronic depolarization (Moulder et al. 2008 ), persistent CB1R activation (Ram ırez-Franco et al. 2014 or during development (Yao et al. 2006) . Presynaptic silencing has also been associated with impairment of the release machinery, and it is related with a decrease in the active zone proteins RIM and Munc13-1 (Jiang et al. 2010; Lazarevic et al. 2011) , as well as with a reduction in the readily releasable pool of SVs (Moulder et al. 2004) . However, the signaling pathway linking the decrease in cAMP to the alterations in the release machinery that cause silencing is not known. Our data indicate that Epac2 and PLC activity can mediate this signaling: Epac as a cAMP target; and PLC to generate diacylglycerol (DAG), which activates Munc13 proteins, a component of the tripartite Munc13/RIM/Rab3 complex essential for the docking and priming of SVs (Dulubova et al. 2005) . We found that partial knockdown of Epac2 in cerebellar granule cells abolishes the ability of the Epac activator 8pCpt to prevent HU-210-induced silencing, while pharmacological inhibition of Epac2 increases the number of silent synaptic boutons. Moreover, Epac2 inhibition abolishes the capacity of 8pCpt to prevent HU-210-induced silencing.
Epac proteins mediate many of the presynaptic cAMP responses at central synapses. Epac proteins act as cAMP effectors in the potentiation of neurotransmitter release (Kaneko and Takahashi 2004; Gekel and Neher 2008) , in SV recruitment to release sites (Sakaba and Neher 2003) , in spontaneous and evoked release (Yang et al. 2012) , in presynaptic forms of synaptic plasticity (Fernandes et al. 2015) , in b-AR-mediated potentiation of glutamate release (Ferrero et al. 2013) , as well as in spatial learning (Yang et al. 2012) .
Interestingly, we found that the PLC inhibitor U-73122 increased the number of silent synaptic boutons, and it abolished Epac activation from both preventing HU-210-induced silencing, consistent with PLC signaling downstream of Epac2 proteins. A link between Epac2 and PLC has already been established in non-neuronal secretory pancreatic b cells (Kwan et al. 2007; Dzhura et al. 2011) , in sperm exocytosis (Branham et al. 2009; Lucchesi et al. 2016 ) and in cerebrocortical nerve terminals (synaptosomes : Ferrero et al. 2013) . The guanine exchange activity of Epac proteins activates the monomeric Rap1 and Rap2 G-proteins of the Ras superfamily (Kawasaki et al. 1998) , which bind to and activate PLC-e (Schmidt et al. 2001) . Indeed, in nonneuronal secretory systems, Epac2 activates PLC-e to enhance insulin secretion (Dzhura et al. 2011) . In cerebrocortical synaptosomes, Epac-mediated potentiation of glutamate release was dependent on PLC and the increase in phosphatidylinositol 4,5 bisphosphate hydrolysis induced by Epac was attenuated by PLC inhibition (Ferrero et al. 2013) . Thus, the increase in the number of silent synaptic boutons upon PLC inhibition is consistent with the involvement of PLC activity in Epac signaling. As such, PLC activity provides a functional link between Epac-mediated responses and the release machinery, whereby Munc13 may be activated through DAG generation, which promotes the docking and priming of SVs dependent on the Munc13/ RIM1/Rab3A tripartite complex (Dulubova et al. 2005) . In fact, Epac2 directly interacts with RIM proteins (Ozaki et al. 2000; Branham et al. 2009) , and moreover, Epac2 À/À mice are deficient in some synaptic proteins including the scaffolding protein calcium/calmodulin-dependent serine protein kinase, the SV membrane protein synaptoporin and the vesicle associated protein Rab3A (Fernandes et al. 2015) . We propose that CB1R-induced silencing is the consequence of decreased cAMP levels and Epac2 activity, which dampens Munc13-1 translocation to plasma membranes through decreased PLC activity and DAG production. Impairing Munc13-1 from reaching the plasma membrane would limit the formation of Munc13/RIM heterodimers, and that of the Munc13/RIM/Rab3A trimeric complex upon binding to SV protein Rab3, thereby reducing the membrane docking and priming of SVs (Betz et al. 2001; Dulubova et al. 2005; Deng et al. 2011; Ma et al. 2011) . Accordingly, CB1R-induced presynaptic silencing is associated with a decrease in the number of SVs close to the AZ in the plasma membrane. Cerebellar granule cells from wild-type mice contain virtually no silent synaptic boutons while the lack of RIM1a increases the proportion of basally silent nerve terminals to 12.9 AE 3.5%. RIMs are multidomain proteins that are fundamental for the organization of the active zone (Mittelstaedt et al. 2010) . RIM1a and RIM2a contain all RIM domains, including the Rab3 and Munc13-1-binding domains (Schoch et al. 2006) . Although RIM2a is coexpressed with RIM1a in many cells, including cerebellar granule cells (Schoch et al. 2006 ), RIM2a does not compensate for the lack of RIM1a in all cells. Thus, the lack of RIM1a alters neurotransmitter release (Schoch et al. 2002; Calakos et al. 2004) , the release probability, short- term plasticity and the size of the readily releasable pool of SVs (Schoch et al. 2002; Calakos et al. 2004) . The long forms of RIMs activate SVs for priming by recruiting and stabilizing Munc13 proteins at the AZ (Betz et al. 2001; Deng et al. 2011 ). Thus, it is possible that the lack of RIM1a reduces the number of release sites. RIM proteins recruit Ca 2+ channels to presynaptic AZs , and the loss of RIM1a also results in weaker Ca 2+ influx into cerebellar granule cells (Kintscher et al. 2013) . It is likely that in RIM1a KO cells, the release machinery is not functional in a subpopulation of nerve terminals as a consequence of the reduced Ca 2+ influx, the reduction in the readily releasable pool of SVs, and the uncoupling between Ca 2+ influx and exocytosis. In addition to the basally silent population, the activation of CB1R further silences nerve terminals in RIM1a KO cells. It is likely that RIM2a-expressing nerve terminals undergo HU-210-dependent silencing in RIM1a KO cells.
In conclusion, nerve terminals may be permanently silenced by the loss of proteins essential for the release machinery like RIM1a (basal silencing), or they may be transiently silenced by down-regulating the cAMP/Epac2/ PLC pathway driven by CB1R.
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